(Q43922950)

English

The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole

scientific article published on 28 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole (English)

1 reference

Europe PubMed Central

28 November 2017

2

1 reference

Europe PubMed Central

28 November 2017

Federico Turkheimer

3

1 reference

Europe PubMed Central

28 November 2017

10

1 reference

Europe PubMed Central

28 November 2017

author name string

Euitae Kim

1

1 reference

Europe PubMed Central

28 November 2017

Bo-Hyung Kim

4

1 reference

Europe PubMed Central

28 November 2017

Jae Min Jeong

5

1 reference

Europe PubMed Central

28 November 2017

Ji Who Kim

6

1 reference

Europe PubMed Central

28 November 2017

Jae Sung Lee

7

1 reference

Europe PubMed Central

28 November 2017

In-Jin Jang

8

1 reference

Europe PubMed Central

28 November 2017

Sang-Goo Shin

9

1 reference

Europe PubMed Central

28 November 2017

Jun Soo Kwon

11

1 reference

Europe PubMed Central

28 November 2017

publication date

28 December 2012

1 reference

Europe PubMed Central

28 November 2017

Psychopharmacology

1 reference

Europe PubMed Central

28 November 2017

227

1 reference

Europe PubMed Central

28 November 2017

2

1 reference

Europe PubMed Central

28 November 2017

221-229

1 reference

Europe PubMed Central

28 November 2017

https://scigraph.springernature.com/pub.10.1007/s00213-012-2953-0

0 references

The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Relationship between the corticostriatal terminals from areas 9 and 46, and those from area 8A, dorsal and rostral premotor cortex and area 24c: an anatomical substrate for cognition to action

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Prefrontal cortical projections to the midbrain in primates: evidence for a sparse connection.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

The nature of dopamine dysfunction in schizophrenia and what this means for treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

The dopamine hypothesis of schizophrenia: version III--the final common pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Elevated striatal dopamine function linked to prodromal signs of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Normal database of dopaminergic neurotransmission system in human brain measured by positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

The concurrent validity of the N-back task as a working memory measure

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Quantification of F-18 FDG PET images in temporal lobe epilepsy patients using probabilistic brain atlas

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationship

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Taq1A polymorphism in the dopamine D2 receptor gene predicts brain metabolic response to aripiprazole in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Simplified reference tissue model for PET receptor studies.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Cerebral metabolism and risperidone treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Low striatal and extra-striatal D2 receptor occupancy during treatment with the atypical antipsychotic sertindole

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

The associative striatum: organization of cortical projections to the dorsocentral striatum in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-012-2953-0

21 January 2018

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271192

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271192

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Highly restricted origin of prefrontal cortical inputs to striosomes in the macaque monkey

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271192

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271192

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271192

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The contribution of astrocytes to the 18F-2-deoxyglucose signal in PET activation studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271192

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine effects on glucose metabolic rate in striatum and frontal cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/23271192

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-012-2953-0

1 reference

Europe PubMed Central

28 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43922950&oldid=2104414640"